Lundbeck

Sustainability Report and Carbon Intensity Rankings

Is Lundbeck doing their part?

Their DitchCarbon score is 62

Lundbeck has a DitchCarbon Score of 62, indicating a moderate level of sustainability in their operations. This score reflects the company’s efforts to manage and reduce its carbon intensity. A higher score would signify even greater success in minimizing their environmental impact through lower carbon emissions.

This was calculated based on 30+ company specific emissions data points, the higher the score, the better. Check out our methodology.

Industry emissions intensity

Very low

Low

Medium

High

Very high

Lundbeck operates in the health and social services industry, which has a low carbon intensity ranking. Some industries are more damaging than others, this ranking gives you an indication of how carbon intensive the industry is which this company operates in.

Location emissions intensity

Very low

Low

Medium

High

Very high

Lundbeck is situated in Denmark, a country with a very low carbon intensity rating. This favorable environmental context supports the company’s sustainability efforts by providing a cleaner energy grid and lower carbon footprint for its operations.

Unlock 30+ emissions data points on Lundbeck

Get the emissions intelligence you need, no surveys required.

– Historical Scope 1, 2 and 3 emissions

– Coverage of all industries, product level data

– Emissions forecasting, assurances

Unlock 30+ emissions data points on Lundbeck

Get the emissions intelligence you need, no surveys required.

– Historical Scope 1, 2 and 3 emissions

– Coverage of all industries, product level data

– Emissions forecasting, assurances

20.44%

...this company is doing 20.44% better in emissions than the industry average.

Founded in 1915 and headquartered in Copenhagen, Denmark, Lundbeck is a leading pharmaceutical company in the health and social services industry. Specializing in the development and provision of innovative treatments for psychiatric and neurological disorders, Lundbeck offers a range of products for conditions such as depression, schizophrenia, Parkinson’s disease, and Alzheimer’s disease. With a strong commitment to research and development, the company operates globally, employing over 5,300 people and distributing its pharmaceuticals in more than 100 countries.

emission intelligence's platform recommendations for Lundbeck

Lundbeck should engage with their suppliers to foster emissions reduction strategies, potentially decreasing their emissions by 25% in their purchased goods and services category.

Good news, Lundbeck has set science-based climate targets

Lundbeck has established Science Based Targets initiative (SBTi) commitments to significantly reduce their greenhouse gas emissions from company operations, which include direct emissions and indirect emissions from purchased energy. These targets align with the global effort to limit temperature rise to 1.5°C, reflecting the company’s dedication to contributing to climate action.
Participating

Claim this profile

Are you associate with this company?
Help us improve our data and claim this profile.

Our methodology

Read about our emission calculation methodologies, and what the DitchCarbon Score means.

Looking for a specific company?

Search our company directory or contact us for custom data requests.